Home page > Code of ethics, compliance and disclosure
 

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data

Code of ethics, compliance and disclosure

Ethics & Compliance / Code of Ethics & Compliance

 

The Code of Ethics and Compliance expresses the Group’s commitment to operate not only in accordance with the laws and regulations currently in force but also with certain principles and rules of conduct of an ethical nature.

 

The application of the following principles is guaranteed by the existence of procedures within the Group aimed at ensuring that its employees, internal bodies and third parties acting on its behalf, operate effectively in accordance with ethical principles.

 

This version of the Code has been approved by the Board of Directors of Chiesi Farmaceutici S.p.A. in 2015. This constitutes an official Group document and as such is binding upon all the bodies, employees, consultants, collaborators, agents and, at a more general level all third parties acting on behalf of the Group.

 

Chiesi Group Guidelines on Ethics & Compliance Edition

Anti Bribery

 

EFPIA

As a member of EFPIA (European Federation of Pharmaceutical Industries and Associations) we are fostering the transparency on the interaction between the pharmaceutical industry and health care professionals & organisations according EFPIA, as well as all national legal regulations, as we are convinced to be independent partners with the same goal: cooperation and exchange of knowledge, as well as research and development without tortious interference or influence.

 

Disclosure DATA:

 

INDIVIDUAL DISCLOSURE

Donations and grants to HCO, HCP’s organisations and associations, organisations providing healthcare;

Costs related to Events: registration fees, sponsorship agreements, travel and accommodation;

Fees for Service and Consultancy to HCPs and HCOs: fees and related expenses must be disclosed separately. This is only applicable, when the HCPs or HCOs have provided their consent on the individual disclosure, otherwise the data needs to be published in the aggregated disclosure data

 

AGGREGATE DISCLOSURE

R&D costs: including costs for related events (investigators’ meetings, etc);

Transfers of value which cannot be disclosed on an individual basis for legal reasons

 

Disclosure DATA  - 1st of January 2015 - 31 December 2015

Disclosure DATA  - 1st of January 2016 - 31 December 2016

Disclosure DATA  - 1st of January 2017 - 31 December 2017 , Methodology 2017

Disclosure DATA  - 1st of January 2018 - 31 December 2018 , Methodology 2018

 

Disclaimer: Publication of transfers of value to Recipients aims at reporting the values (monetary or in-kind) to HCPs/HCOs our company is collaborating / has relationships with, following the objectives and provisions included in the applicable codes.  Individual disclosures have been consented to by individual Recipients – such consent has been given to allow complying with the applicable codes that our company signed off to. These publications do not grant a general permission for those accessing our website or the national platforms to undertake additional processing of the healthcare professionals’ data.

For a good understanding of the reporting included in our disclosures as published on this website, we refer to the Methodological Note that clarifies the meaning and content of the transfers of value reported.

For more questions on the EFPIA code or concerning a disclaimer or revocation of your consent to the individual disclosure, do not hesitate to contact uson the EFPIA code or concerning a disclaimer or revocation of your consent to the individual disclosure, do not hesitate to contact us.